Bayesian gamma frailty models for survival data with semi-competing risks and treatment switching

Lifetime Data Analysis

Volumn 20, Issue 1, 2014, Pages 76-105

  Zhang, Yuanye ^a   Chen, Ming Hui ^b   Ibrahim, Joseph G ^c   Zeng, Donglin ^c   Chen, Qingxia ^d   Pan, Zhiying ^e   Xue, Xiaodong ^e  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c The University of North Carolina at Chapel Hill   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e AMGEN INC   (United States)

Author keywords

Competing risks; Panitumumab; Partial treatment switching; Posterior propriety; Semi Markov model

Indexed keywords

MONOCLONAL ANTIBODY; PANITUMUMAB;

ALGORITHM; ARTICLE; BAYES THEOREM; COLORECTAL TUMOR; COMPUTER SIMULATION; DISEASE COURSE; HUMAN; PATHOLOGY; STATISTICAL MODEL; SURVIVAL;

ALGORITHMS; ANTIBODIES, MONOCLONAL; BAYES THEOREM; COLORECTAL NEOPLASMS; COMPUTER SIMULATION; DISEASE PROGRESSION; HUMANS; MODELS, STATISTICAL; SURVIVAL ANALYSIS;

EID: 84891902050     PISSN: 13807870     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10985-013-9254-8     Document Type: Article

References (22)

1. Aalen OO, Johansen S, Johansen S (1978) An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand J Stat 5: 141-150.
2. Amado RG, Wolf M, Peeters M, van Cutsem E, Siena S, Freeman DJ, Juan T, Sikorski R, Suggs S, Radinsky R, Patterson SD, Chang DD (2008) Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol 28: 1626-1634.
3. Andersen PK, Borgan O, Gill RD, Keiding N (1993) Statistical models based on counting processes. Springer, New York.
4. Banerjee T, Chen MH, Dey DK, Kim S (2007) Bayesian analysis of generalized odds-rate hazards models for survival data. Lifetime Data Anal 13: 241-260.
5. Chen MH, Shao QM (2001) Propriety of posterior distribution for dichotomous quantal response models with general link functions. Proc Am Math Soc 129: 293-302.
6. Chen MH, Shao QM, Ibrahim JG (2000) Monte Carlo methods in Bayesian computation. Springer, New York.
7. Day R, Bryant J (1997) Adaptation of bivariate frailty models for prediction, with application to biological markers as prognostic indicators. Biometrika 84: 45-56.
8. Fine JP, Jiang H, Chappell R (2001) On semi-competing risks data. Biometrika 88: 907-919.
9. Gilks WR, Wild P (1992) Adaptive rejection sampling for Gibbs sampling. Appl Stat 41: 337-348.
10. Ghosh D (2006) Semiparametric inferences for association with semi-competing risks data. Stat Med 25: 2059-2070.
11. Ibrahim JG, Chen MH, Sinha D (2001) Bayesian Surv Anal. Springer, New York.
12. Liu JS (1994) The collapsed Gibbs sampler in Bayesian computations with applications to a gene regulation problem. J Am Stat Assoc 89: 958-966.
13. Mandel M (2010) The competing risks illnessCdeath model under cross-sectional sampling. Biostatistics 11: 290-303.
14. Marcus SM, Gibbons RD (2001) Estimating the efficacy of receiving treatment in randomized clinical trials with noncompliance. Health Serv Outcomes Res Methodol 2: 247-258.
15. Oakes D (1989) Bivariate survival models induced by frailties. J Am Stat Assoc 84: 487-493.
16. Peng L, Fine JP (2007) Regression modeling of semicompeting risks data. Biometrics 63: 96-108.
17. Shen Y, Thall PF (1998) Parametric likelihoods for multiple non-fatal competing risks and death. Stat Med 17: 999-1015.
18. Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A (2002) Bayesian measures of model complexity and fit (with Discussion). J R Stat Soc B 64: 583-639.
19. van Cutsem E, Peeters M, Siena S, Humblet Y, Hendlisz A, Neyn B, Canon JL, van Laethem JL, Maurel J, Richardson G, Wolf M, Amado RG (2007) Open-label Phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J Clin Oncol 25: 1658-1664.
20. Wang W (2003) Estimating the association parameter for copula models under dependent censoring. J R Stat Soc B 65: 257-273.
21. Zeng D (2012) Estimating treatment effects with treatment switching via semi-competing risks models: An application to a colorectal cancer study. Biometrika 9: 167-184.
22. Zhao L (2009) Multi-state processes with duration-dependent transition intensities: statistical methods and applications. Unpublished Ph. D. dissertation, Simon Fraser University.